A 35-year-old man with focal seizures refractory to monotherapy is being evaluated for polytherapy. Before adding a second antiepileptic, the neurologist wants to assess baseline hepatic and renal function and establish a baseline for future monitoring. Which investigation is most appropriate to guide drug selection and dosing in this patient?